Physician Wealth Advisors’s Adverum Biotechnologies ADVM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-217
Closed -$984 2032
2025
Q3
$984 Buy
+217
New +$640 ﹤0.01% 1586

Physician Wealth Advisors's ADVM Position: Q4 2025 in Review

Physician Wealth Advisors sold out of Adverum Biotechnologies (ADVM) in Q4 2025, closing a stake of 217 shares — an estimated $984 sold.

Physician Wealth Advisors first reported a position in ADVM in Q3 2025 and held it in 1 quarter. The position peaked at $984 in Q3 2025. 0 funds tracked by Wall St. Rank hold ADVM as of Q4 2025.

  • Physician Wealth Advisors reported no remaining Adverum Biotechnologies position as of Q4 2025 after selling out during the quarter.
  • Physician Wealth Advisors sold 217 Adverum Biotechnologies shares in Q4 2025, an estimated $984.
  • Physician Wealth Advisors first reported a position in Adverum Biotechnologies in Q3 2025 and held it in 1 quarter.
  • Physician Wealth Advisors's Adverum Biotechnologies position peaked at $984 in Q3 2025.
  • 0 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q4 2025.

Based on Physician Wealth Advisors's 13F filing for Q4 2025, filed 29 Jan 2026.